The Second Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu, China.
Department of Cardiovascular Surgery, Changhai Hospital, Naval Military Medical University, Shanghai, 200433, China.
BMC Cardiovasc Disord. 2022 Dec 12;22(1):543. doi: 10.1186/s12872-022-02972-4.
To compare mitral valve (MV) repair and concomitant maze procedure with catheter ablation in treating patients with atrial functional mitral regurgitation (AFMR).
We retrospectively identified 126 patients with AFMR from January 2012 to December 2015. Of these patients, 60 patients underwent MV repair and concomitant maze procedure, and 66 patients received catheter ablation. Patients were followed up for 7.98 ± 2.01 years. The survival, readmission of heart failure (HF), persistent atrial fibrillation (AF), persistent moderate-severe mitral regurgitation (MR) and tricuspid Regurgitation (TR), and echocardiographic data were analyzed in the follow-up. Predictors of readmission of HF were analyzed.
There was no significant difference in baseline and echocardiographic characteristics, in-hospital mortality, and other adverse events postoperatively between two groups. The surgical group was associated with lower rates of MR > 2 + grade either at discharge (P = 0.0023) or in the follow-up (P = 0.0001). There was no significant difference in the incidence of overall survival between the two groups. The surgical group was associated with a lower rate of readmission of HF and AF in the follow-up. Univariable and multivariable analysis confirmed AF at discharge, moderate-severe MR at discharge, no MV surgery, moderate-severe TR at discharge, and LA volume as predictors of readmission of HF. Both groups experienced significant reverse cardiac remodeling.
Our results suggest that for the treatment of AFMR with persistent or long-standing persistent AF and moderate-severe MR, MV repair and concomitant maze procedure may achieve a better outcome than catheter ablation procedure.
比较二尖瓣(MV)修复和同期迷宫手术与导管消融治疗心房功能性二尖瓣反流(AFMR)的疗效。
我们回顾性分析了 2012 年 1 月至 2015 年 12 月期间 126 例 AFMR 患者。其中 60 例行 MV 修复和同期迷宫手术,66 例行导管消融。患者随访 7.98±2.01 年。分析随访期间的生存、心力衰竭(HF)再入院、持续性房颤(AF)、持续性中重度二尖瓣反流(MR)和三尖瓣反流(TR)以及超声心动图数据。分析 HF 再入院的预测因素。
两组患者的基线和超声心动图特征、住院死亡率及术后其他不良事件无显著差异。手术组出院时(P=0.0023)和随访时(P=0.0001)MR>2+级的发生率较低。两组间总生存率无显著差异。手术组 HF 和 AF 的再入院率较低。单变量和多变量分析证实出院时的 AF、出院时的中重度 MR、无 MV 手术、出院时的中重度 TR 和左心房容积是 HF 再入院的预测因素。两组均经历了明显的逆向心脏重构。
我们的研究结果表明,对于持续性或长期持续性 AF 和中重度 MR 的 AFMR 患者,MV 修复和同期迷宫手术可能比导管消融术有更好的疗效。